Table 4
Most common adverse events in European Monotherapy Study
Patients (%)
Placebo (n=121)
IL1Ra (n=351)
Injection site reaction
25
68
Exacerbation of RA
33
21
Arthralgia
12
8
Abdominal pain
5
7
Upper respiratory tract infection
7
7